Kinetic and affinity constants of epitope specific anti-carcinoembryonic antigen (CEA) monoclonal antibodies for CEA and engineered CEA domain constructs

Immunotechnology

Volumn 4, Issue 1, 1998, Pages 49-57

  Hefta, Laura J F ^a   Neumaier, Michael ^b   Shively, John E ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

BIAcore; Carcinoembryonic antigen; Monoclonal antibody

Indexed keywords

ANTIGEN; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; DISULFIDE; EPITOPE; SYNTHETIC PEPTIDE;

AFFINITY CHROMATOGRAPHY; ANTIBODY AFFINITY; ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; GENETIC ENGINEERING; HUMAN; HUMAN CELL; IMMUNOGLOBULIN STRUCTURE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIGEN-ANTIBODY REACTIONS; CARCINOEMBRYONIC ANTIGEN; EPITOPES; GENETIC ENGINEERING; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY;

EID: 0031812099     PISSN: 13802933     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1380-2933(98)00004-9     Document Type: Article

References (17)

1. Shively J.E., Beatty J.D. CRC Crit Rev Onc/Hem. 2(4):1985;355-399.
2. McLaughlin J.P., Schlom J., Kantor J.A., Greiner J.W. Cancer Res. 56:1996;2361-2367.
3. Tsang K.Y., Zaremba S., Nieroda C.A., Zhu M., Hamilton J.M., Schlom J. J Natl Cancer Inst. 87:1995;982-990.
4. Conry R.M., LoBuglio A.F., Loechel F., Moore S.E., Sumerel L., Barlow D.L., Curiel D.T. Gene Ther. 2:1995;59-65.
5. Tsujisaki M., Imai K., Tokuchi S., Hanzawa Y., Ishida T., Kitagawa H., Hinoda Y., Yachi A. Cancer Res. 51:1991;2599-2604.
6. Pervin S., Chakraborty M., Bhattacharya-Chatterjee M., Zeytin H., Foon K.A., Chatterjee S.K. Cancer Res. 57:1997;728-734.
7. Foon K.A., Chakraborty M., John W.J., Sherratt A., Kohler H., Bhattacharya-Chatterjee M. J Clin Invest. 96:1995;334-342.
8. Wong J.Y.C., Thomas G.E., Yamauchi D.M., Williams L.E., Odom-Maryon T.L., Esteban J.M., Neumaier M., Wu A.M., Primus F.J., Shively J.E., Raubistchek A.A. J Nucl Med. 38:1997;1951-1959.
9. Wong J.Y.C., Williams L.E., YYamauchi D.M., Odom-Maryon T.L., Esteban E.M., Neumaier M., Wu A.M., Johnson D.K., Primus F.J., Shively J.E., Raubitschek A.A. Cancer Res. 55:1995;5929s-5934s.
10. Hammarstrom S., Shively J.E., Paxton R.J., Beatty B.G., Larsson A., Ghosh R., Bormer O., Buchegger F., Mach J.-P., Burtin P., Seguin P., Darbouret B., Degorce F., Sertour J., Jolu J.P., Fuks A., Kalthoff H., Schmiegel W., Arndt R., Kloppel G., von Kleist S., Grunert F., Schwarz K., Matsuoka Y., Kuroki M., Wagener C., Weber T., Yachi A., Imai K., Hishikawa N., Tsujisaki M. Cancer Res. 49:1989;4852-4858.
11. Hass G.M., Bolling T.J., Kinders R.J., Henslee J.G., Mandecki W., Dorwin S.A., Shively J.E. Cancer Res. 51:1991;1876-1882.
12. Hefta L.J.F., Chen F.-S., Ronk M., Sauter S.L., Sarin V., Oikawa S., Nakazato H., Hefta S., Shively J.E. Cancer Res. 52:1992;5647-5655.
13. Slayter H.S., Coligan J.E. Cancer Res. 36:1976;1696-1704.
14. Beidler C.B., Ludwig J.R., Cardenas J., Phelps J., Papworth C.G., Melcher E., Sierzega M., Myers L.J., Unger B.W., Fisher M., David G.S., Johnson J. J Immunol. 141(11):1988;4053-4060.
15. Gaida F.-J., Pieper D., Roder U.W., Shively J.E., Wagener C., Neumaier M. J Biol Chem. 268:1993;14138-14145.
16. Hefta LJ, Wu AM, Neumaier M, Shively JE. In: McCafferty J, Hoogenboom HR, Chiswell DJ, editors. Antibody Engineering: A Practical Approach. New York: Oxford University Press, 1996:99-117.
17. Neumaier M., Shively L., Chen F.-S., Gaida F.-J., Ilgen C., Paxton R.J., Shively J.E., Riggs A.D. Cancer Res. 50:1990;2128-2134.